Schedule 13D ownership disclosure
EIGER BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 28249U105
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-21-009003
- Form type
- SC 13D
- Filer
- Eiger BioPharmaceuticals, Inc.
- CIK
- CIK 1305253
- Filed
- Feb 12, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13D beneficial ownership